AbbVie to acquire Allergan in “transformative move”
Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...
Novartis acquires IFM Tre
Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...
GHO Capital acquires Sterling Pharma Solutions
European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...
Healthtech M&A and IPO Activity
The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...
DoseCare acquires Biodose
DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...
UK pharma pressing ahead with M&As in 2019
The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...
Sanofi and Denali join forces on inflammatory disease drugs
Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...
AstraZeneca divests rights for Nexium and Vimovo to Grünenthal
AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...
Mundipharma acquires biosimilars development company
The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...
BioIVT acquires CTLS a UK blood donor facility
BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...
Latest articles
Servier and UCL collaborate on immune-inflammatory disease treatments
Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...
Forendo and Novartis partner on novel chronic liver disease treatments
Forendo and Novartis are to partner on novel chronic liver disease treatments. Forendo Pharma, a clinical stage drug development company focusing on novel treatments...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial
Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Popular articles
Living well with HIV and AIDS around the world
1st December is World AIDS Day which raises awareness of HIV and AIDS around the world. There have been huge leaps in the treatment...
AstraZeneca and MSD’s Lynparza™ now available in Scotland
AstraZeneca and MSD's Lynparza™ is now available in Scotland as the companies announce that olaparib monotherapy is now accepted for use by the Scottish...
How are LifeArc collaborating to advance research and science for patient benefit?
Melanie Lee CBE is Chief Executive of LifeArc, a self-funded medical research charity that is working in collaboration to translate early science for patient...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial
Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Merging CCGs to align commissioning
Julie Das-Thompson, Head of Policy and Delivery at NHS Clinical Commissioners, researches how 2020 will see the merging of at least 20 clinical commissioning...